BCCA-UBC Medical Oncology Program

Canada

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for BCCA-UBC Medical Oncology Program published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: BCCA-UBC Medical Oncology Program is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.09

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.09
1 0.09

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 53.09% Domestic
  • 46.91% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (3 total)

  • BCCA-UBC Medical Oncology Program, Canada
  • Domestic institution
  1. Trillium Therapeutics Inc., Canada (0.15)
    0.09
    0.05
  2. Simon Fraser University (SFU), Canada (0.12)
    0.09
    0.03
  3. Terry Fox Laboratory, Canada (0.11)
    0.09
    0.02

Top 10 international collaborators by Share (3 total)

  • BCCA-UBC Medical Oncology Program, Canada
  • Foreign institution
  1. National Institutes of Health (NIH), United States of America (USA) (0.13)
    0.09
    0.04
  2. Ulm University, Germany (0.10)
    0.09
    0.01
  3. Okayama University, Japan (0.10)
    0.09
    0.01

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

BCCA-UBC Medical Oncology Program is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs